Neurology Trials

Return to Full Search

Note: Trials may appear under more than one keyword.


Alzheimer's Disease

Brain Cancer


Parkinson's Disease


Multiple Sclerosis


Movement Disorders

Cognitive Dysfunction/Impairment

Memory Loss, Memory Problems, and Memory Disorders

Huntington's Disease

Cerebral Palsy

Biomarker/Genetic Marker Study

Myasthenia Gravis

All Trials for Neurology

A Phase II Trial of Rituximab in Myasthenia Gravis (NN103)

Adults with relapsing MS for research study

Are you a caregiver of a person with memory loss?

Children and Adolescents 10 – 17 for Multiple Sclerosis Study

Men and women 55 and older, currently on treatment, wanted for MS study

Parkinson’s Disease study for adults

Patients with Parkinson’s Dyskinesia wanted for Focused Ultrasound Study

Research Study For Adults Age 60-85 At Increased Risk For Developing Alzheimer’s Disease

Research study for adults ages 50-85 with Prodromal Alzheimer’s disease

Research Study for Adults Diagnosed with Alzheimer's Disease on Donepezil

Research Study For Adults Diagnosed with Dementia with Lewy Bodies

Research study for adults with and at risk for Huntington’s Disease

Research study for adults with early stage Parkinson’s Disease

Research Study for Adults with Parkinson’s Disease

Research Study for Adults with Progressive MS

Research Study for adults with Radiologically Isolated Syndrome (RIS)

Research study for adults with relapsing-remitting MS

Research study for adults with relapsing-remitting Multiple Sclerosis (MS) having a relapse

Research study for children ages 2 to 8 years old with Cerebral Palsy.

Research Study for those with Subcortical Epilepsy

Seeking Adults with Newly Diagnosed Glioblastoma

Seeking adults with Parkinson’s disease experiencing “OFF” episodes

Seeking Adults with Progressive Meningiomas

STAIR: An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD)

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Women and Men 18 to 65 with relapsing-remitting MS for research study